| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5697000 | Brachytherapy | 2017 | 9 Pages |
Abstract
Permanent prostate brachytherapy dosimetry based only on MRI using positive contrast MRI markers is feasible, accurate, and reduces the uncertainties arising from CT-MRI fusion abating the need for postimplant multimodality imaging.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
Geoffrey V. Martin, Thomas J. Pugh, Usama Mahmood, Rajat J. Kudchadker, Jihong Wang, Teresa L. Bruno, Tharakeswara Bathala, Pierre Blanchard, Steven J. Frank,